
Primary headache disorders are a major cause of disability and a common reason people seek medical care. However, distinguishing a primary from a secondary headache disorder, as well as among primary headache disorders, is often challenging. Focusing on cluster and migraine, Drs. Jessica Ailani and Stewart Tepper provide criteria and strategies to overcome this challenge in the office setting. Insight is also provided to help guide treatment with evidence-based medications and devices, including new options. The real-world use of shared decision-making to individualize patient management and improve patient outcomes is brought to life through the use of whiteboard animation.
Course Credit:
1.50 ACPE Contact Hours
1.50 AMA PRA Category 1 CreditsTM
1.50 ANCC Contact Hours
Dates:
Opens: 2020-12-14
Closes: 2021-12-14
Target Audience:
This activity was developed for headache specialists, neurologists, primary care physicians, pain specialists, OB/GYNs, nurses, nurse practitioners, physician assistants, pharmacists, medical students, residents, and other clinicians who care for patients with primary headache disorders.
This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
-
Jessica Ailani, MD, FAHS
Director
MedStar Georgetown Headache Center
Associate Professor of Neurology Medstar Georgetown University Hospital
Washington, DC -
Gregory Scott, PharmD
WriteHealth, LLC
Kennebunk, Maine -
Stewart J. Tepper, MD
Professor of Neurology
Geisel School of Medicine at Dartmouth
Hanover, New Hampshire
Director, Dartmouth Headache Center
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Downloads
Learning Objectives
- Apply guideline-based diagnostic and evaluation strategies to diagnose and differentiate migraine from cluster headache and other primary and secondary headache disorders
- Evaluate acute and preventative pharmacological therapies to develop an individualized treatment plan
- Foster stronger patient adherence through shared decision
- Utilize the shared decision-making process with patients who have a primary headache disorder to individualize treatment
Faculty Disclosures
Jessica Ailani, MD, FAHS
Advisory Board
- AbbVie, Axsomem, Biohaven, Impel, Lilly, Satsuma,Teva
Consultant
- AbbVie, Biohaven, Lilly, Lundbeck, Satsuma
Research Support
- AbbVie, Biohaven, Lilly, Zosano
Speakers Bureau
- AbbVie, Biohaven, Lilly, Lundbeck, Teva
Gregory Scott, PharmD
No significant relationship to disclose
Stewart J. Tepper, MD
Research Support
- Allergan, Amgen, Dr. Reddy’s, ElectroCore, Eli Lilly, eNeura, Lundbeck, Neurolief, Novartis, Satsuma, Scion Neurostim, Teva, Zosano
Consultant and/or Advisory Board
- Acorda, Aeon, Alexza, Align Strategies, Allergan, Alphasights, Amgen, Aperture Venture Partners, Aralez Pharmaceuticals Canada, Axsome Therapeutics, Becker Pharmaceutical Consulting, BioDelivery Sciences International, Biohaven, Charleston Labs, CRG, Currax, Decision Resources, DeepBench, Eli Lilly, eNeura, Equinox, ExpertConnect, GLG, GSK, Guidepoint Global, Healthcare Consultancy Group, Health Science Communications, Impel, Lundbeck, M3 Global Research, Magellan Rx Management, Marcia Berenson Connected Research and Consulting, Medicxi, Navigant Consulting, Neurolief, Nordic BioTech, Novartis, Pulmatrix, Reckner Healthcare, Relevale, Revance, SAI MedPartners, Satsuma, Scion Neurostim, Slingshot Insights, Sorrento, Spherix Global Insights, Sudler and Hennessey, Synapse Medical Communications, Teva, Theranica, Thought Leader Select, Trinity Partners, XOC, Zosano
Stock options
- Nocira, Percept
Accreditation and Certification
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

A maximum of 1.50 contact hours may be earned for successful completion of this activity.
Additional Content Planners
Eugene Cullen, MD (Peer Reviewer)No significant relationship to disclose
Heather M. Jimenez, FNP-C (Nurse Planner)
No significant relationships to disclose.
Gregory Scott, PharmD, RPh (Medical Writer)
No significant relationships to disclose.
Annenberg Center for Health Sciences
All members of the Eisenhower Health Education Committee have no relevant commercial relationships to disclose.